Back to Agenda
RISK COMMUNICATION
Session Chair(s)
Marin Banovac
Scientific Officer, European Medicines Agency, Netherlands
Juan Garcia-Burgos, MD, PhD
Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands
In recent years, EMA has taken several measures to improve patients’ access to information on the safety of medicines and on actions planned to manage the important risks of EU medicines. The session on risk communication will bring together the patients, the regulators and the industry in a trilateral discussion on risk communication and better understanding of the patients’ needs and expectations in this respect.
Speaker(s)
The role of regulators in communicating benefits and risks
Juan Garcia-Burgos, MD, PhD
Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands
Effective risk communication- can we shift the paradigm and why it matters
James Milligan
Vice President Pharmacovigilance and Risk Management, Seqirus UK Limited, United Kingdom
Patient Perspective
David Haerry
Patient Advocate, EATG, Switzerland
Have an account?